Skip to content

IMIN: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

IMIN

BE 0807.053.559
NACE 86.220, Specialist medical practice
NACE division 86, Human health activities all sizesfiscal years 2020 to 202411,004 to 23,194 sector peers per ratio

Summary

fiscal year 2024

IMIN does better than half of its sector on 1 of the 8 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Interest coveragebetter than 73%
Points to watch
  • Current ratiobetter than 13%
  • Working-capital ratiobetter than 15%
  • Return on equitybetter than 27%

Solvency and debt

How soundly the company is financed.
Solvency
60.0%▼2024

Solvency is below 57% of 23,194 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Debt to equity
0.67▲2024

Debt to equity is above 61% of 22,851 sector peers: less favourable than the median.

Position against the sector weakening since 2020.

20202021202220232024
Long-term debt ratio
0.53▲2024

The long-term debt ratio is above 60% of 11,004 sector peers: less favourable than the median.

Position against the sector stable since 2020.

20202021202220232024
Interest coverage
170.03▲2024

Interest coverage is above 73% of 22,054 sector peers: more favourable than the median.

Position against the sector improving since 2020.

20202021202220232024

Liquidity

Whether it can pay its short-term bills.
Current ratio
0.87▼2024

The current ratio is below 87% of 22,867 sector peers: in the least favourable quarter.

Position against the sector weakening since 2020.

20202021202220232024
Working-capital ratio
-1.0%▼2024

The working-capital ratio is below 85% of 23,171 sector peers: in the least favourable quarter.

Position against the sector weakening since 2020.

20202021202220232024

Profitability

What the company earns on its assets and its sales.
Return on equity
16.4%▲2024

Return on equity is below 73% of 21,737 sector peers: less favourable than the median.

Position against the sector improving since 2020.

20202021202220232024
Return on assets
9.8%▲2024

Return on assets is below 72% of 23,151 sector peers: less favourable than the median.

Position against the sector improving since 2020.

20202021202220232024

Not computable

Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.